On October 30, 2023 Qingdao Yuanjia Medical Technology proposal to Hangzhou TianMuShan Pharmaceutical Enterprise About Adding Shang Xiaofan to the Company's Eleventh Board of Directors during the Fourth Extraordinary General Meeting of Shareholders in 2023 was approved.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.89 CNY | +4.59% | +11.82% | -23.76% |
1st Jan change | Capi. | |
---|---|---|
-23.76% | 149M | |
+25.80% | 661B | |
+26.74% | 566B | |
-6.62% | 352B | |
+20.41% | 332B | |
+3.24% | 283B | |
+13.47% | 231B | |
+4.74% | 200B | |
-9.37% | 195B | |
-5.22% | 145B |
- Stock Market
- Equities
- 600671 Stock
- News Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd
- Qingdao Yuanjia Medical Treatment Technology proposal of Adding Sheng Xiaofan to the Company's Eleventh Board of Directors to Hangzhou TianMuShan Pharmaceutical Enterprise was approved.